Aims: Studies indicate that doctors may be reluctant to discuss smoking with their patients. Knowledge about how this problem might be solved is limited. The aim of this study was to identify barriers for engaging in tobacco prevention in general practice.
Methods: An anonymous questionnaire was mailed to 3,167 randomly selected general practitioners (GPs) in Sweden Norway, Finland, and Iceland. The questionnaire identified practice and barriers for the discussion of smoking and smoking cessation with patients and the GPs' own smoking behaviour.
Results: The overall response rate was 67%. A large majority of the GPs perceived the discussion of patients' smoking habits as part of their job. However, most GPs did not enquire about smoking unless the patient had smoking-related symptoms and few engaged in smoking cessation support. Many GPs felt that smoking cessation support was too time consuming and that the time spent was not effective because few patients quit. Shortage of smoking cessation experts to whom patients could be referred was the most common barrier for systematic involvement in smoking cessation support. On average, GPs had spent approximately one hour during the previous month on smoking cessation support.
Conclusion: The main barriers identified in this study indicate that smoking cessation expertise needs to be more accessible. One alternative is to establish telephone help-lines (Quit-lines) that are easily available for all and could serve as a back-up for the GPs. Another more costly approach is to develop smoking cessation expertise at major clinics. A combination of both is probably the best solution.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14034940210133799 | DOI Listing |
J Basic Clin Physiol Pharmacol
January 2025
Department of Clinical Pharmacology, 29988 JIPMER , Pondicherry, India.
Objectives: Acute myocardial infarction is a critical medical condition that poses a significant risk to life. It is distinguished by the abrupt cessation of blood flow to a specific segment of the cardiac muscle. Acute myocardial infarction accounts for more than 15 % of global mortality annually.
View Article and Find Full Text PDFTob Induc Dis
January 2025
Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, United States.
Introduction: Cigarette smoking is an important risk factor in the development of dyspnea. Programs designed to strengthen the respiratory muscles can improve dyspnea in people with or without lung disease. As a first step in understanding the feasibility of offering a respiratory muscle training (RMT) program to people who are seeking help to try to quit smoking, we asked callers who contacted the New York State Quitline about their dyspnea and potential interest in a home-based RMT program.
View Article and Find Full Text PDFRev Med Suisse
January 2025
Département vulnérabilités et médecine sociale, Unisanté, 1011 Lausanne.
In this article, we present eight studies published in the past two years that are likely to influence general practice in 2025. The key messages highlight the importance of physical activity in reducing cardiovascular risk, the effectiveness of aripiprazole for treatment-resistant depression, and the positive impact of guidelines on antibiotic use for acute cystitis. Furthermore, teleconsultation is more effective when supported by a pre-existing therapeutic relationship, extended leave reduces physician burnout, electronic cigarettes aid smoking cessation, and AI improves the management of electronic communications.
View Article and Find Full Text PDFJ Health Popul Nutr
January 2025
Department of Public Health Sciences, University of Rochester Medical Center, Saunders Research Building Crittenden Blvd, Rochester, New York, 14642, USA.
Background: No study has assessed the impact of flavor capsule cigarettes (FCCs) on smoking cessation. Thus, the purpose of this exploratory study was to assess (1) the sociodemographic and smoking-related characteristics associated with using FCCs, and (2) the preliminary impact of FCCs on smoking cessation.
Methods: This study is a secondary data analysis of a single-arm study with 100 individuals living in Mexico who smoked and received a smoking cessation mHealth intervention and pharmacotherapy support.
Contemp Clin Trials
January 2025
Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA; Department of Psychology, University of South Florida, Tampa, FL, USA; Department of Oncological Sciences, University of South Florida, Tampa, FL, USA. Electronic address:
Background: Augmented Reality (AR) is a rapidly developing technology with potential utility for treating addictive behaviors, including tobacco smoking. AR inserts digital images into a natural real-time scene as viewed on a smartphone or other video devices. With respect to smoking cessation, AR can place virtual smoking cues (i.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!